Circulating cytokines associated with clinical outcomes in advanced non‐small cell lung cancer patients who received chemoimmunotherapy-Reference-Cited by-同舟云学术

Circulating cytokines associated with clinical outcomes in advanced non‐small cell lung cancer patients who received chemoimmunotherapy

Published:2021-11-25 Issue:2 Volume:13 Page:219-227
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Shi Yuequan¹^ORCID,Liu Xiaoyan¹,Du Juan²,Zhang Dongming¹,Liu Jia¹,Chen Minjiang¹^ORCID,Zhao Jing¹,Zhong Wei¹,Xu Yan¹^ORCID,Wang Mengzhao¹

Affiliation:

1. Department of Respiratory and Critical Care Medicine Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China

2. Department of Clinical Laboratory Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14248

Reference38 articles.

1. PD-L1 Expression, Tumor Mutational Burden, and Cancer Gene Mutations Are Stronger Predictors of Benefit from Immune Checkpoint Blockade than HLA Class I Genotype in Non–Small Cell Lung Cancer

2. Peripheral blood markers predictive of outcome and immune-related adverse events in advanced non-small cell lung cancer treated with PD-1 inhibitors

3. Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment

4. Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition

5. High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Analysis of Immune Responses to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer;Annals of Surgical Oncology;2024-08-27

2. Peripheral blood cytokines and outcomes with immune checkpoint blockade: a systematic review and meta-analysis;Immunotherapy;2024-08-19

3. Prognostic impact of Interleukin-8 levels in lung cancer: A meta-analysis and a bioinformatic validation;Lung Cancer;2024-08

4. Prognostic role of circulating cytokines and inflammation indexes for avelumab maintenance in metastatic urothelial carcinoma;Frontiers in Immunology;2024-05-10

5. The CLCF1-CNTFR axis drives an immunosuppressive tumor microenvironment and blockade enhances the effects of established cancer therapies;2024-03-22